Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
-20.39%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$26.1B
AUM Growth
-$17B
(-39%)
Cap. Flow
-$6.87B
Cap. Flow
% of AUM
-26.29%
Top 10 Holdings %
Top 10 Hldgs %
12.41%
Holding
2,672
New
335
Increased
1,090
Reduced
994
Closed
233
Top Buys
| 1 |
Microsoft
MSFT
|
+$317M |
| 2 |
Apple
AAPL
|
+$310M |
| 3 |
Coca-Cola
KO
|
+$232M |
| 4 |
Verizon
VZ
|
+$199M |
| 5 |
JPMorgan Chase
JPM
|
+$189M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$362M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$297M |
| 3 |
Cisco
CSCO
|
+$291M |
| 4 |
Costco
COST
|
+$290M |
| 5 |
Meta Platforms (Facebook)
META
|
+$282M |
Sector Composition
| 1 | Technology | 18.36% |
| 2 | Healthcare | 16.64% |
| 3 | Consumer Discretionary | 11.59% |
| 4 | Financials | 11.58% |
| 5 | Industrials | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENZ
2151
DELISTED
Enzo Biochem, Inc.
ENZ
| $210K | ﹤0.01% |
82,957
-21,100
| -20% | -$53.4K |
|
|
NETI
2152
DELISTED
Eneti Inc.
NETI
| $210K | ﹤0.01% |
+8,300
| New | +$210K |
|
2153
Akebia Therapeutics
AKBA
$795M
| $209K | ﹤0.01% |
+27,606
| New | +$209K |
|
2154
Johnson Controls International
JCI
$70.1B
| $208K | ﹤0.01% |
+7,700
| New | +$208K |
|
2155
Merchants Bancorp
MBIN
$1.51B
| $208K | ﹤0.01% |
20,550
-13,800
| -40% | -$140K |
|
|
ONCY
2156
Oncolytics Biotech
ONCY
$141M
| $208K | ﹤0.01% |
+150,700
| New | +$208K |
|
2157
RCI Hospitality Holdings
RICK
$307M
| $207K | ﹤0.01% |
20,800
+1,400
| +7% | +$13.9K |
|
2158
SmartFinancial
SMBK
$639M
| $207K | ﹤0.01% |
13,600
-500
| -4% | -$7.61K |
|
|
OYST
2159
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $207K | ﹤0.01% |
+5,900
| New | +$207K |
|
2160
Microchip Technology
MCHP
$35.2B
| $206K | ﹤0.01% |
6,074
-50,352
| -89% | -$1.71M |
|
|
KG
2161
Kestrel Group, Ltd.
KG
$199M
| $206K | ﹤0.01% |
11,302
-4,455
| -28% | -$81.2K |
|
2162
Solid Biosciences
SLDB
$389M
| $206K | ﹤0.01% |
5,747
+4,894
| +574% | +$175K |
|
2163
Alaunos Therapeutics
TCRT
$4.83M
| $205K | ﹤0.01% |
+559
| New | +$205K |
|
2164
Veru
VERU
$49.4M
| $205K | ﹤0.01% |
+6,270
| New | +$205K |
|
|
TGI
2165
DELISTED
Triumph Group
TGI
| $204K | ﹤0.01% |
30,200
+900
| +3% | +$6.08K |
|
2166
Iridium Communications
IRDM
$2.04B
| $203K | ﹤0.01% |
9,100
-300
| -3% | -$6.69K |
|
2167
National Bank Holdings
NBHC
$1.5B
| $203K | ﹤0.01% |
+8,500
| New | +$203K |
|
2168
Cadence Bank
CADE
$7.04B
| $202K | ﹤0.01% |
+10,700
| New | +$202K |
|
2169
Commerce Bancshares
CBSH
$8.04B
| $202K | ﹤0.01% |
+5,112
| New | +$202K |
|
2170
Acacia Research
ACTG
$326M
| $200K | ﹤0.01% |
90,015
-2,900
| -3% | -$6.44K |
|
2171
Cerus
CERS
$247M
| $199K | ﹤0.01% |
42,700
-13,700
| -24% | -$63.8K |
|
|
SRGA
2172
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $199K | ﹤0.01% |
3,879
-274
| -7% | -$14.1K |
|
2173
KALA BIO
KALA
$102M
| $198K | ﹤0.01% |
+450
| New | +$198K |
|
2174
Harvard Bioscience
HBIO
$20.2M
| $197K | ﹤0.01% |
89,356
-13,200
| -13% | -$29.1K |
|
|
BELFB
2175
Bel Fuse Class B
BELFB
$1.79B
| $194K | ﹤0.01% |
19,915
+2,200
| +12% | +$21.4K |
|